MariMed to Speak on Cannabis Real Estate Challenges at NEREJ Summit June 13


MariMed to share insights from their cannabis operations in 6 states

NEWTON, MA and BOSTON, MA, June 08, 2018 (GLOBE NEWSWIRE) -- Three MariMed Inc. (OTCQB: MRMD) executives will share their expertise on successfully securing real estate for cannabis businesses at the New England Real Estate Journal’s (NEREJ) 2018 Cannabis & Commercial Real Estate (CRE Summit.   MariMed CEO Robert Fireman, CFO Jon Levine and COO Tim Shaw will provide real experiences gained from developing marijuana cultivation, production and dispensary facilities in six states and decades of collective executive experience in commercial real estate at The Summit’s two panels.  The Cannabis & CRE Summit is 9:30 a.m. to noon, Wednesday, June 13 at the Boston Convention and Exhibition Center, 415 Summer St., Boston. The Summit runs concurrently in the same location with the New England Builders and Facilities Management (NEBFM ’18) Conference.

“There are many issues and challenges involved in siting and developing cannabis facilities in Massachusetts and other states where cannabis has legal medical and adult use programs,” stated Robert Fireman, MariMed CEO.  “It requires not only a good understanding of the state law, but also a thorough review of each municipality’s zoning, ordinances, and sentiment towards cannabis.  We are looking forward to sharing our hard earned insight and helping attendees connect with critical resources that can streamline their efforts.  We are delighted to help others enter this new and emerging industry.  Cannabis is providing relief to patients and users for all sorts of symptoms and conditions! We believe cannabis is the most important medicinal plant on Earth and has the power to transform human health and wellness.”

The two Cannabis & CRE Summit panel topics are:

  • Laws and Restrictions to Operate, Zoning and Permitting
  • Retail and Industrial Space Needed for Operations

The panelists include:

  • Camilo Basto, ABG Commercial Realty,
  • Brian Anderson, Partner, Anderson Porter Design,
  • Kevin Conroy, Esq., Partner, Foley Hoag, LLP
  • Robert Fireman, Esq., CEO, MariMed
  • Frank Flynn, Esq., Owner, Managing Partner, Flynn Law Group
  • Bernard Gibbons, President, ABG Commercial Realty
  • Jon Levine, CFO, MariMed 
  • Tim Shaw, COO, MariMed

 “As Massachusetts nears legalization of cannabis, many aspiring cannabis entrepreneurs are struggling with how to overcome the real estate challenges it involves,” stated NEREJ Director of Events Rick Kaplan. “By bringing together experienced professionals in real estate, law and design with stakeholders in various areas of the cannabis industry, we believe the Summit offers a great education and networking opportunity that can play an important role in the success of cannabis businesses.”

Register for the Summit at

Search MariMed and post on social media with the hash tag #MedicatedByMarimed:
Twitter: @MariMedInc    
Facebook: @MariMedInc
Instagram:  MariMedInc
YouTube: MariMedInc

About MariMed Inc.:

MariMed designs, develops, finances, and optimizes the success of medical cannabis cultivation, production, and dispensary facilities through its validated management. MariMed’s team has developed or is in the process of developing state-of-the-art regulatory-compliant facilities in DE, IL, NV, MD, MA, and RI. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. In addition, MariMed is on the forefront of precision dosed branded products for the treatment of specific medical symptoms. MariMed currently distributes its branded products in select states and is expanding licensing and distribution to numerous additional states encompassing thousands of dispensaries. MariMed Inc. is one of the 17 top-performing public cannabis companies in the U.S. tracked on the U.S. Marijuana Index, ( For additional information, visit

Forward Looking Statements:

This release contains certain forward-looking statements and information relating to MariMed Inc., that is based on the beliefs of MariMed Inc.’s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected" or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.


Contact Data